Washington, D.C. 20549

                                    FORM 8-K

                Current Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

Date of Report (Date of earliest event report):  March 10, 2006

                            AMS HEALTH SCIENCES, INC.
             (Exact name of registrant as specified in its charter)

   OKLAHOMA                  001-13343                   73-1323256
   --------                  ---------                   ----------
(State or other           (Commission File             (IRS Employer
jurisdiction of                 Number)                Identification
 incorporation)                                            Number)

                   711 NE 39th Street, Oklahoma City, OK 73105
               (Address of Principal Executive Offices) (Zip Code)

       Registrant's telephone number, including area code: (405) 842-0131

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR

[ ] Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17
    CFR 240.14a-12(b))

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c))

Information to be Included in the Report

Item 5.02.  Departure of Directors or Principal Officers;  Election of Directors
            Appointment of Principal Officers.

     On March 10, 2006, AMS Health Sciences, Inc. (AMEX: AMM) announced that the
Board of  Directors  had  approved  the  appointment  of  Stephen E. Jones as an
independent director of the Company. Mr. Jones was appointed to fill the vacancy
left by the  resignation  of Brent Haggard in January  2006.  Mr. Jones has been
appointed  to serve on the audit  and  compensation  committees  of the board of

Item 9.01.  Financial Statements and Exhibits

     (c) Exhibits

99.1 Press release dated March 10, 2006


     Pursuant to the  requirements  of the  Securities and Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereto duly authorized.

                                              AMS HEALTH SCIENCES, INC.

                                                   JERRY W. GRIZZLE
                                              By:  Jerry W. Grizzle
                                                   Chairman, President and Chief
                                                   Executive Officer

Date:  March 17, 2006

                                  EXHIBIT INDEX

  No.              Description                     Method of Filing
  ---              -----------                     ----------------

99.1   Press release dated March 17, 2006    Filed herewith electronically